Yalei Lv

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Mechanism of action and therapeutic value of anoctamin-1 in gastrointestinal cancers.

Mechanism of action and therapeutic value of anoctamin-1 in gastrointestinal cancers.

Journal: Frontiers in immunology
Published: March 24, 2025

Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model.

Comprehensive evaluation of breast cancer immunotherapy and tumor microenvironment characterization based on interleukin genes-related risk model.

Journal: Scientific reports
Published: September 17, 2022

Correlation between immune-related adverse events and treatment efficacy of anti-PD1 immunotherapy in patients with esophageal squamous cell carcinoma.

Correlation between immune-related adverse events and treatment efficacy of anti-PD1 immunotherapy in patients with esophageal squamous cell carcinoma.

Journal: Oncology letters
Published: July 27, 2022

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?

Journal: BMC cancer
Published: May 19, 2022

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2- patients with metastatic breast cancer.

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2- patients with metastatic breast cancer.

Journal: Medicine
Published: July 27, 2021

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway.

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway.

Journal: Journal of hepatocellular carcinoma
Published: July 05, 2021

Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.

Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.

Journal: Medicine
Published: January 02, 2021

Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway.

Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway.

Journal: Aging
Published: January 01, 2021

Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.

Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.

Journal: Cancer gene therapy
Published: November 06, 2020

Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice.

Effect of bevacizumab combined with chemotherapy at different sequences in the gastric-cancer-bearing nude mice.

Journal: Journal of cancer research and therapeutics
Published: March 27, 2018

miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.

miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.

Journal: Cancer gene therapy
Published: July 20, 2017

Bevacizumab followed by chemotherapy is potential therapy for gastric cancer.

Bevacizumab followed by chemotherapy is potential therapy for gastric cancer.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: January 01, 2017
Showing 1-12 of 19

Last Updated: 09/26/2026